Empire Life Investments’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-150,082
Closed -$15.8M 113
2021
Q1
$15.8M Sell
150,082
-14,075
-9% -$1.43M 1.09% 36
2020
Q4
$16.7M Buy
164,157
+752
+0.5% +$70.7K 1.18% 32
2020
Q3
$13.7M Sell
163,405
-525
-0.3% -$40.9K 1.1% 32
2020
Q2
$10.6M Sell
163,930
-624
-0.4% -$41.2K 0.94% 36
2020
Q1
$10.7M Buy
+164,554
New +$13M 0.98% 33

Other funds holding XYL

Empire Life Investments's XYL Position: Q2 2021 in Review

Empire Life Investments sold out of Xylem (XYL) in Q2 2021, closing a stake of 150,082 shares — an estimated $15.8M sold.

Empire Life Investments first reported a position in XYL in Q1 2020 and held it in 5 quarters. The position peaked at $16.7M in Q4 2020. 771 funds tracked by Wall St. Rank hold XYL as of Q2 2021.

  • Empire Life Investments reported no remaining Xylem position as of Q2 2021 after selling out during the quarter.
  • Empire Life Investments sold 150,082 Xylem shares in Q2 2021, an estimated $15.8M.
  • Empire Life Investments first reported a position in Xylem in Q1 2020 and held it in 5 quarters.
  • Empire Life Investments's Xylem position peaked at $16.7M in Q4 2020.
  • 771 funds tracked by Wall St. Rank held Xylem as of Q2 2021.

Based on Empire Life Investments's 13F filing for Q2 2021, filed 4 Aug 2021.